JPS5782400A - Erythromycin derivative - Google Patents

Erythromycin derivative

Info

Publication number
JPS5782400A
JPS5782400A JP55159128A JP15912880A JPS5782400A JP S5782400 A JPS5782400 A JP S5782400A JP 55159128 A JP55159128 A JP 55159128A JP 15912880 A JP15912880 A JP 15912880A JP S5782400 A JPS5782400 A JP S5782400A
Authority
JP
Japan
Prior art keywords
formula
solvent
reaction
compound
catalyst
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP55159128A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6152839B2 (en, 2012
Inventor
Yoshiaki Watanabe
Shigeo Morimoto
Sadafumi Omura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP55159128A priority Critical patent/JPS5782400A/ja
Priority to US06/266,060 priority patent/US4331803A/en
Priority to EP81302328A priority patent/EP0041355B1/en
Priority to DE8181302328T priority patent/DE3160084D1/de
Priority to AT81302328T priority patent/ATE2623T1/de
Publication of JPS5782400A publication Critical patent/JPS5782400A/ja
Publication of JPS6152839B2 publication Critical patent/JPS6152839B2/ja
Priority to NL930083C priority patent/NL930083I2/nl
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP55159128A 1980-06-04 1980-11-12 Erythromycin derivative Granted JPS5782400A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP55159128A JPS5782400A (en) 1980-11-12 1980-11-12 Erythromycin derivative
US06/266,060 US4331803A (en) 1980-06-04 1981-05-19 Novel erythromycin compounds
EP81302328A EP0041355B1 (en) 1980-06-04 1981-05-27 Novel erythromycin compounds
DE8181302328T DE3160084D1 (en) 1980-06-04 1981-05-27 Novel erythromycin compounds
AT81302328T ATE2623T1 (de) 1980-06-04 1981-05-27 Erythromycin-derivate.
NL930083C NL930083I2 (nl) 1980-06-04 1993-06-21 Nieuwe erytromycineverbindingen.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55159128A JPS5782400A (en) 1980-11-12 1980-11-12 Erythromycin derivative

Publications (2)

Publication Number Publication Date
JPS5782400A true JPS5782400A (en) 1982-05-22
JPS6152839B2 JPS6152839B2 (en, 2012) 1986-11-14

Family

ID=15686846

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55159128A Granted JPS5782400A (en) 1980-06-04 1980-11-12 Erythromycin derivative

Country Status (1)

Country Link
JP (1) JPS5782400A (en, 2012)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0915898A1 (en) 1996-07-29 1999-05-19 Abbott Laboratories Crystal form i of clarithromycin
EP0915899A1 (en) 1996-07-29 1999-05-19 Abbott Laboratories Preparation of crystal form ii of clarithromycin
EP1077988A1 (en) 1997-01-17 2001-02-28 Abbott Laboratories Crystal form 0 of clarithromycin
WO2007129646A1 (ja) 2006-05-01 2007-11-15 Taisho Pharmaceutical Co., Ltd. マクロライド誘導体

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0915898A1 (en) 1996-07-29 1999-05-19 Abbott Laboratories Crystal form i of clarithromycin
EP0915899A1 (en) 1996-07-29 1999-05-19 Abbott Laboratories Preparation of crystal form ii of clarithromycin
JP2000515894A (ja) * 1996-07-29 2000-11-28 アボツト・ラボラトリーズ クラリスロマイシンの結晶フォーム▲ｉ▼
JP2009242411A (ja) * 1996-07-29 2009-10-22 Abbott Lab クラリスロマイシンの結晶形態ｉｉの製造
JP2010090156A (ja) * 1996-07-29 2010-04-22 Abbott Lab クラリスロマイシンの結晶フォームｉ
JP2013151542A (ja) * 1996-07-29 2013-08-08 Abbott Lab クラリスロマイシンの結晶形態ｉｉの製造
EP1077988A1 (en) 1997-01-17 2001-02-28 Abbott Laboratories Crystal form 0 of clarithromycin
WO2007129646A1 (ja) 2006-05-01 2007-11-15 Taisho Pharmaceutical Co., Ltd. マクロライド誘導体

Also Published As

Publication number Publication date
JPS6152839B2 (en, 2012) 1986-11-14

Similar Documents

Publication Publication Date Title
JPS62149695A (ja) エリスロマイシンａ誘導体の選択的メチル化方法
EP0141057A1 (en) Novel 4'-demethyl-4-epipodophyllotoxin derivatives, a process for their preparation and their use as medicaments
US3338888A (en) Rifamycin type antibiotic compounds
JPS6345282A (ja) アシル基及び置換アルキル基を有するリフアマイシン誘導体
JPS5782400A (en) Erythromycin derivative
PT85513B (pt) Processo para a preparacao de derivados da pirimidina e de composicoes farmaceuticas que os contem
JP3466527B2 (ja) 新規なアコニチン系化合物および鎮痛・抗炎症剤
Beélik et al. Some new reactions and derivatives of kojic acid
DE2167181B1 (de) Methyl-N-acetyl-6,7-aziridino-6-desamino-7-desoxy-2,3,4-tri-0-acetyl-alpha-thiolincosaminid und Verfahren zu dessen Herstellung
JP2000503666A (ja) Ｍａｐｐｉａ ｆｏｅｔｉｄａから単離したカンプトセシン―骨格化合物および新規な医薬ならびに治療薬のためのシントンとしてのその使用
Depreux et al. Synthesis of benzil from benzoin with copper (II) acetate
DE2524394A1 (de) Alpha-aminomethyl-3-aethyl-4-hydroxybenzylalkoholderivate, verfahren zu ihrer herstellung und arzneimittel
JPS577438A (en) Production of acid chloride
CN116804017B (zh) 汉防己甲素的合成方法
JPS55144422A (en) Purification of cis-dichlorodiammineplatinum(2)
JP2770357B2 (ja) ヌクレオシド誘導体の製造方法
JPS56103197A (en) Novel d-glucose derivative and antitumor agent containing the same as active constitutent
Jones et al. Nucleophilic aromatic substitution with elimination in a dinitrosalicylic lactone or ester via Meisenheimer intermediates
JPS63250394A (ja) ３−アシルアミノ−３−デオキシアロ−ス誘導体
JPS6335579A (ja) 含硫ベンゾキサジノリフアマイシン誘導体
US3759946A (en) 1-aryloxy-4,5-diphenylimidazoles
US2463831A (en) Amino alkyl benzoates
Bodurow et al. 2, 2-dimethyl-6-[(triphenylphosphoranylidene) methyl]-4h-1, 3-dioxin-4-one. A four-carbon homologating agent requiring no activation
AT300844B (de) Verfahren zur Herstellung von neuen D-Arabitolverbindungen
CA1049035A (en) Process for the preparation of triesters and products thus obtained

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term